Type 2 deiodinase Thr92Ala polymorphism and aging are associated with a decreased pituitary sensitivity to thyroid hormone
Abstract
Background: The DIO2 Thr92Ala polymorphism (rs225014), which occurs in about 15–30% of Caucasian people, determines a less efficient type 2 deiodinase (D2) enzyme. The aim of this study was to determine the impact of DIO2 Thr92Ala polymorphism on the serum thyrotropin (TSH) levels in thyroidectomized patients with hypothyroidism and to evaluate whether TSH levels and aging could be related, at pituitary level, to D2 activity. Methods: This prospective study was performed on 145 thyroid cancer patients, treated with total thyroidectomy, and undergoing radioiodine treatment after 3 weeks of levothyroxine (LT4) withdrawal. A mouse model has been used to determine D2 protein and mRNA levels in pituitary during aging. Results: Genetic analysis identified DIO2 Thr92Ala polymorphism in 56% of participants: 64/145 (44%) patients were homozygous wild type (WT) (Thr/Thr), 64 (44%) heterozygous (Thr/Ala), and 17 (12%) homozygous mutant (Ala/Ala). A significant negative relationship was observed between aging and the rise in serum TSH levels during LT4 withdrawal. However, this negative correlation found in WT was reduced in heterozygous and lost in mutant homozygous patients (Thr/Thr r = −0.45, p = 0.0002, 95% confidence interval [CI] −0.63 to −0.23; Ala/Thr r = −0.39, p = 0.0012, CI −0.60 to −0.67; and Ala/Ala r = −0.30, p = 0.2347; CI −0.70 to 0.20). Accordingly, when we compared the TSH measured in each patient to its theoretical value predicted from age, the TSH did not reach its putative target in 47% of WT patients, in 70% of Ala/Thr, and 76% of Ala/Ala carrying patients ( p = 0.0036). This difference was lost in individuals older than 60 years, suggesting a decline of D2 associated with aging. The hypothesis that the pituitary D2 decreases with age was confirmed by the evidence that D2 mRNA and protein levels were lower in pituitary from old versus young mice. Conclusion: An age-related decline in TSH production in response to hypothyroidism was correlated with decreased D2 levels in pituitary. The presence of DIO 2 homozygous Ala/Ala polymorphism was associated with a reduced level of TSH secretion in response to hypothyroidism, indicating a decreased pituitary sensitivity to serum thyroxine variation (Institutional Research Ethics board approval number no. 433/21).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Peripheral type 2 deiodinase efficiency becomes relevant in maintaining circulating iodothyronine homeostasis after thyroidectomy.
“Thus, peripheral type 2 deiodinase efficiency becomes relevant in maintaining circulating iodothyronine homeostasis (103).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [103]
Cites
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853 · see citing works
Self-citationSchneider, M. J., Fiering, S. N., Pallud, S. E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0740 · Cited by 376 · see citing works
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360 · see citing works
Type 3 deiodinase is critical for the maturation and function of the thyroid axis
Hernández, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26240 · Cited by 344 · see citing works
Fekete, C., & Lechan, R. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1087 · Cited by 342 · see citing works
Peeters, R. P., van Toor, H., Klootwijk, W., de Rijke, Y. B., Kuiper, G. G. J. M., Uitterlinden, A. G., & Visser, T. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021592 · Cited by 242 · see citing works
An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction
Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hennessey, J. V., Kopp, P. A., Ross, D. S., Samuels, M. H., Sawka, A. M., et al. (2018) · Thyroid · doi:10.1089/thy.2017.0681 · Cited by 231 · see citing works
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205 · see citing works
Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184 · see citing works
Is a Normal TSH Synonymous With “Euthyroidism” in Levothyroxine Monotherapy?
Peterson, S. J., McAninch, E. A., & Bianco, A. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2660 · Cited by 182 · see citing works
Coordination of hypothalamic and pituitary T3 production regulates TSH expression
Fonseca, T. L., Correa-Medina, M., Campos, M. P. O., Wittmann, G., Werneck-de-Castro, J. P., Arrojo e Drigo, R., Mora-Garzon, M., Ueta, C. B., Caicedo, A., Fekete, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61231 · Cited by 155 · see citing works
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Castagna, M. G., Dentice, M., Cantara, S., Ambrosio, R., Maino, F., Porcelli, T., Marzocchi, C., Garbi, C., Pacini, F., & Salvatore, D. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2587 · Cited by 151 · see citing works
Self-citationPrimary hypothyroidism and quality of life
Hegedüs, L., Bianco, A. C., Jonklaas, J., Pearce, S. H., Weetman, A. P., & Perros, P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00625-8 · Cited by 144 · see citing works
Dora, J. M., Machado, W. E., Rheinheimer, J., Crispim, D., & Maia, A. L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0419 · Cited by 132 · see citing works
Schlumberger, M. J., Charbord, P., Fragu, P., Lumbroso, J., Parmentier, C., & Tubiana, M. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-513 · Cited by 128 · see citing works
Self-citationPeeters, R. P., van den Beld, A. W., Attalki, H., Toor, H. V., de Rijke, Y. B., Kuiper, G. G. J. M., Lamberts, S. W. J., Janssen, J. A. M. J. L., Uitterlinden, A. G., & Visser, T. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00571.2004 · Cited by 108 · see citing works
Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain
Jo, S., Fonseca, T. L., Bocco, B. M. L. C., Fernandes, G. W., McAninch, E. A., Bolin, A. P., Da Conceição, R. R., Werneck-de-Castro, J. P., Ignacio, D. L., Egri, P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123176 · Cited by 107 · see citing works
McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01361 · Cited by 94 · see citing works
Torlontano, M., Durante, C., Torrente, I., Crocetti, U., Augello, G., Ronga, G., Montesano, T., Travascio, L., Verrienti, A., Bruno, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1067 · Cited by 92 · see citing works
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Gumieniak, O., Perlstein, T. S., Williams, J. S., Hopkins, P. N., Brown, N. J., Raby, B. A., & Williams, G. H. (2007) · Hypertension · doi:10.1161/01.hyp.0000256295.72185.fd · Cited by 84 · see citing works
Mitchell, A. L., Hegedüs, L., Žarković, M., Hickey, J. L., & Perros, P. (2021) · Clinical Endocrinology · doi:10.1111/cen.14340 · Cited by 81 · see citing works
Grarup, N., Andersen, M. K., Andreasen, C. H., Albrechtsen, A., Borch-Johnsen, K., Jørgensen, T., Auwerx, J. H., Schmitz, O., Hansen, T. F., & Pedersen, O. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1958 · Cited by 66 · see citing works
Marsili, A., Ramadan, W., Harney, J. W., Mulcahey, M. A., Castroneves, L. A., Goemann, I. M., Wajner, S. M., Huang, S. A., Zavacki, A. M., Maia, A. L., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0631 · Cited by 62 · see citing works
Self-citationButler, P. W., Smith, S. M., Linderman, J. D., Brychta, R. J., Alberobello, A. T., Dubaz, O. M., Luzon, J. A., Skarulis, M. C., Cochran, C. S., WESLEY, R. A., et al. (2010) · Thyroid · doi:10.1089/thy.2010.0244 · Cited by 60 · see citing works
A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans
McAninch, E. A., Rajan, K. B., Evans, D. A., Jo, S., Chaker, L., Peeters, R. P., Bennett, D. A., Mash, D. C., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01196 · Cited by 59 · see citing works
Heemstra, K. A., Hoftijzer, H. C., Van Der Deure, W. M., Peeters, R. P., Fliers, E., Appelhof, B. C., Wiersinga, W. M., Corssmit, E. P. M., Visser, T. J., & Smit, J. W. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03474.x · Cited by 51 · see citing works
Age modifies the pituitary TSH response to thyroid failure
Carlé, A., Laurberg, P., Pedersen, I. B., Perrild, H., Ovesen, L., Rasmussen, L. B., Jorgensen, T., & Knudsen, N. (2007) · Thyroid · doi:10.1089/thy.2006.0191 · Cited by 45 · see citing works
Age and the thyrotropin response to hypothyroxinemia
Over, R., Mannan, S., Nsouli-Maktabi, H., Burman, K. D., & Jonklaas, J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0281 · Cited by 45 · see citing works
Luongo, C., Martin, C., Vella, K. R., Marsili, A., Ambrosio, R., Dentice, M., Harney, J. W., Salvatore, D., Zavacki, A. M., & Larsen, P. R. (2014) · Endocrinology · doi:10.1210/en.2014-1698 · Cited by 43 · see citing works
Self-citationvan der Deure, W. M., Peeters, R. P., Uitterlinden, A. G., Albert Hofman, D., Breteler, M. M. B., Witteman, J. C. M., & Visser, T. J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03447.x · Cited by 22 · see citing works
Montesano, T., Durante, C., Attard, M., et al. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.04.001 · Cited by 19 · see citing works
Maia, A. L., Hwang, S., Levy, D. A., Larson, M. G., Larsen, P. R., & Fox, C. S. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109454 · Cited by 18 · see citing works
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back
Rurale, G., Cicco, E. D., Dentice, M., Salvatore, D., Persani, L., Marelli, F., & Luongo, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00912 · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Centanni, M., Duntas, L., Feldt-Rasmussen, U., Koehrle, J., Peeters, R. P., Razvi, S., Trimboli, P., & Virili, C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0123 · Cited by 38 · see citing works
“Thus, peripheral type 2 deiodinase ef fi ciency becomes relevant in maintaining circulating iodothyronine homeostasis (103).”
- Authors
- Luongo, C., De Stefano, M. A., Ambrosio, R., Volpe, F., Porcelli, T., Golia, V., Bellevicine, C., Troncone, G., Masone, S., Damiano, V., Matano, E., Klain, M., Schlumberger, M., & Salvatore, D.
- Affiliations
- University of Naples Federico II (IT)
- Department of Public Health, University of Naples “Federico II,” Naples, Italy.
- Istituti di Ricovero e Cura a Carattere Scientifico, Synlab, SDN, Naples, Italy.
- Federico II University Hospital (IT)
- Université Paris-Saclay (FR)
- Corresponding author
- Luongo, Cristina
- Salvatore, Domenico
- ORCID
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2023-03
- Volume
- 33
- Issue
- 3
- Pages
- 294-300
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W4317666726
- Cited by
- 11
- References
- 34
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- type 2 deiodinase, aging, thyroid-stimulating hormone, hypothyroidism, thyroidectomy, radioiodine therapy, levothyroxine withdrawal, genetic polymorphism, thyroid cancer, mouse model
- MeSH terms
- Iodothyronine Deiodinase Type II, Animals, Hypothyroidism, Iodide Peroxidase, Iodine Radioisotopes, Prospective Studies, RNA, Messenger, Thyroid Hormones, Thyrotropin, Thyroxine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review